AIMS/HYPOTHESIS: Autologous progenitor cells represent a promising option for regenerative cell-based therapies. Nevertheless, it has been shown that ageing and cardiovascular risk factors such as diabetes affect circulating endothelial and bone marrow-derived progenitor cells, limiting their therapeutic potential. However, their impact on other stem cell populations remains unclear. We therefore investigated the effects of diabetes on adipose-derived stem cells (ASCs) and whether these effects might limit the therapeutic potential of autologous ASCs. METHODS: A systems biology approach was used to analyse the expression of genes related to stem cell identification in subcutaneous adipose tissue (SAT), the stromal vascular fraction and isolated ASCs from Zucker diabetic fatty rats and their non-diabetic controls. An additional model of type 2 diabetes without obesity was also investigated. Bioinformatic approaches were used to investigate the biological significance of these changes. In addition, functional studies on cell viability and differentiation potential were performed. RESULTS: Widespread downregulation of mesenchymal stem cell markers was observed in SAT of diabetic rats. Gene expression and in silico analysis revealed a significant effect on molecules involved in the maintenance of pluripotency and self-renewal, and on the alteration of main signalling pathways important for stem cell maintenance. The viability and differentiation potential of ASCs from diabetic rats was impaired in in vitro models and in in vivo angiogenesis. CONCLUSIONS/ INTERPRETATION: The impact of type 2 diabetes on ASCs might compromise the efficiency of spontaneous self-repair and direct autologous stem cell therapy.
AIMS/HYPOTHESIS: Autologous progenitor cells represent a promising option for regenerative cell-based therapies. Nevertheless, it has been shown that ageing and cardiovascular risk factors such as diabetes affect circulating endothelial and bone marrow-derived progenitor cells, limiting their therapeutic potential. However, their impact on other stem cell populations remains unclear. We therefore investigated the effects of diabetes on adipose-derived stem cells (ASCs) and whether these effects might limit the therapeutic potential of autologous ASCs. METHODS: A systems biology approach was used to analyse the expression of genes related to stem cell identification in subcutaneous adipose tissue (SAT), the stromal vascular fraction and isolated ASCs from Zucker diabetic fattyrats and their non-diabetic controls. An additional model of type 2 diabetes without obesity was also investigated. Bioinformatic approaches were used to investigate the biological significance of these changes. In addition, functional studies on cell viability and differentiation potential were performed. RESULTS: Widespread downregulation of mesenchymal stem cell markers was observed in SAT of diabeticrats. Gene expression and in silico analysis revealed a significant effect on molecules involved in the maintenance of pluripotency and self-renewal, and on the alteration of main signalling pathways important for stem cell maintenance. The viability and differentiation potential of ASCs from diabeticrats was impaired in in vitro models and in in vivo angiogenesis. CONCLUSIONS/ INTERPRETATION: The impact of type 2 diabetes on ASCs might compromise the efficiency of spontaneous self-repair and direct autologous stem cell therapy.
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: Liping Xiao; Takanori Sobue; Alycia Esliger; Mark S Kronenberg; J Douglas Coffin; Thomas Doetschman; Marja M Hurley Journal: Bone Date: 2010-05-25 Impact factor: 4.398
Authors: Anne Limbourg; Merlin Ploom; Diana Elligsen; Inga Sörensen; Tibor Ziegelhoeffer; Achim Gossler; Helmut Drexler; Florian P Limbourg Journal: Circ Res Date: 2007-01-18 Impact factor: 17.367
Authors: In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley Journal: Nature Date: 2007-12-23 Impact factor: 49.962
Authors: C Garcés; M J Ruiz-Hidalgo; J Font de Mora; C Park; L Miele; J Goldstein; E Bonvini; A Porrás; J Laborda Journal: J Biol Chem Date: 1997-11-21 Impact factor: 5.157
Authors: Fernando Ugarte; Martin Ryser; Sebastian Thieme; Fernando A Fierro; Katrin Navratiel; Martin Bornhäuser; Sebastian Brenner Journal: Exp Hematol Date: 2009-07 Impact factor: 3.084
Authors: Vivian Capilla-González; Javier López-Beas; Natalia Escacena; Yolanda Aguilera; Antonio de la Cuesta; Rafael Ruiz-Salmerón; Franz Martín; Abdelkrim Hmadcha; Bernat Soria Journal: Mol Ther Date: 2018-08-16 Impact factor: 11.454
Authors: Wilfredo Oliva-Olivera; Antonio Leiva Gea; Said Lhamyani; Leticia Coín-Aragüez; Juan Alcaide Torres; Maria Rosa Bernal-López; Pedro Pablo García-Luna; Salvador Morales Conde; Sonia Fernández-Veledo; Rajaa El Bekay; Francisco José Tinahones Journal: Endocrinology Date: 2015-09-15 Impact factor: 4.736
Authors: Laura M Pérez; Aurora Bernal; Beatriz de Lucas; Nuria San Martin; Annalaura Mastrangelo; Antonia García; Coral Barbas; Beatriz G Gálvez Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240